Developability considerations for bispecific and multispecific antibodies
Bispecific antibodies (bsAb) and multispecific antibodies (msAb) encompass a diverse variety of formats that can concurrently bind multiple epitopes, unlocking mechanisms to address previously difficult-to-treat or incurable diseases. Early assessment of candidate developability enables demotion of...
Saved in:
Main Authors: | Alaa Amash (Author), Gesa Volkers (Author), Patrick Farber (Author), Daniel Griffin (Author), K. Shawn Davison (Author), Allison Goodman (Author), Raffi Tonikian (Author), Aaron Yamniuk (Author), Bryan Barnhart (Author), Tim Jacobs (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Engineering a pure and stable heterodimeric IgA for the development of multispecific therapeutics
by: Florian Heinkel, et al.
Published: (2022) -
"Stapling" scFv for multispecific biotherapeutics of superior properties
by: Lauren E. Boucher, et al.
Published: (2023) -
Modulation of Multispecific Transporters by <i>Uncaria tomentosa</i> Extract and Its Major Phytoconstituents
by: Nóra Szilvásy, et al.
Published: (2024) -
Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters
by: Ágnes Telbisz, et al.
Published: (2021) -
Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models
by: Delphine Valente, et al.
Published: (2020)